Music Therapy for Chronic Pain
(POP SINGER 1 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Conduct a single-arm pilot study (N = 24) to examine the feasibility and acceptability of the hybrid (i.e., half in-person, half online) POPSINGER group Music Therapy (MT) intervention.
Who Is on the Research Team?
Angelique Foss, CHES®, NBC-HWC, LPMT, MT-BC
Principal Investigator
University Hospitals Cleveland Medical Center
Samuel N Rodgers-Melnick, PhD, MPH, LPMT, MT-BC
Principal Investigator
University Hospitals Cleveland Medical Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Music Therapy Intervention
Participants receive a total of 16 music therapy sessions (8 in-person and 8 virtual) focusing on self-management of pain through various music interventions
Follow-up
Participants are monitored for retention, session attendance, and completion of follow-up measures
What Are the Treatments Tested in This Trial?
Interventions
- Music Therapy
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
A board-certified music therapist will provide a total of 16 MT sessions (8 in-person and 8 virtual) that include education, social connection, and experiential music interventions. These sessions will focus on self-management of pain through evidenced-based MT interventions including music sharing, playlists using the iso-principle, music making, music and guided imagery, music and deep breathing, progressive muscle relaxation, and adapted cardio drumming.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Hospitals Cleveland Medical Center
Lead Sponsor
Kulas Foundation
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.